We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Micron Biomedical

News List

Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children prnewswire
July 14, 2021
Micron Biomedical, Inc. ("Micron" or the "Company"), a leader in dissolving, microneedle-based vaccine and drug delivery, today announced that it has initiated a Phase 1/2 clinical trial of its microneedle-based measles-rubella ("MR") vaccine.
Micron Progresses with Clinical Evaluation of Measles-Rubella Vaccination Technology americanpharmaceuticalreview
September 03, 2020
Micron Biomedical recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation.